Madam Chair, as I responded to his colleague, we are focused on ensuring that Canadians have affordable medication that meets their needs and that can be delivered at a cost Canadians can afford, and so we continue the work that we started in our previous mandate.
In regard to the specific drug that I assumed the member is referring to, that applicant has yet to apply to Canada to market its drug here.